Author Archives: Holly May

Understanding The Business Model Of Gene Therapy Companies – Peeling The Onion Back To Understand Why Time Matters
November 4, 2021

By Deanna Petersen and Holly May, Chief Business Officer and Chief Commercial Officer, respectively, of AVROBIO, as part of the From The Trenches feature of LifeSciVC Moving from traditional drug development and commercialization to gene therapy development and commercialization can

Leave a comment